Marion Lapierre

965 total citations
22 papers, 428 citations indexed

About

Marion Lapierre is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Marion Lapierre has authored 22 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in Marion Lapierre's work include Estrogen and related hormone effects (6 papers), Cancer-related Molecular Pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). Marion Lapierre is often cited by papers focused on Estrogen and related hormone effects (6 papers), Cancer-related Molecular Pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). Marion Lapierre collaborates with scholars based in France, United States and United Kingdom. Marion Lapierre's co-authors include Vincent Cavaillès, Stéphan Jalaguier, Sandrine Bonnet, Abdel‐Majid Khatib, Catherine Teyssier, Nathalie Scamuffa, Malcolm G. Parker, Fabien Calvo, Yannick Bontemps and Géraldine Siegfried and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Cancer Research.

In The Last Decade

Marion Lapierre

22 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion Lapierre France 12 278 142 96 71 58 22 428
Margarite D. Matossian United States 14 314 1.1× 258 1.8× 136 1.4× 41 0.6× 52 0.9× 39 588
BaoHan T. Vo United States 12 335 1.2× 114 0.8× 107 1.1× 51 0.7× 42 0.7× 15 502
Vijay Menon United States 14 367 1.3× 139 1.0× 82 0.9× 27 0.4× 75 1.3× 28 593
Kristina Althoff Germany 14 547 2.0× 154 1.1× 197 2.1× 47 0.7× 85 1.5× 21 727
Jörg Hartkamp Germany 11 426 1.5× 130 0.9× 63 0.7× 33 0.5× 66 1.1× 16 541
Katarzyna Wójcik‐Krowiranda Poland 9 299 1.1× 79 0.6× 184 1.9× 46 0.6× 51 0.9× 28 435
William J. Muller Canada 5 437 1.6× 209 1.5× 93 1.0× 61 0.9× 63 1.1× 5 622
Kiran Nakka Canada 13 500 1.8× 82 0.6× 148 1.5× 37 0.5× 67 1.2× 18 642
M. Ángeles Villaronga Spain 17 420 1.5× 139 1.0× 162 1.7× 44 0.6× 41 0.7× 28 577
Suzana Gomes United States 8 326 1.2× 103 0.7× 103 1.1× 35 0.5× 72 1.2× 14 448

Countries citing papers authored by Marion Lapierre

Since Specialization
Citations

This map shows the geographic impact of Marion Lapierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Lapierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Lapierre more than expected).

Fields of papers citing papers by Marion Lapierre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Lapierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Lapierre. The network helps show where Marion Lapierre may publish in the future.

Co-authorship network of co-authors of Marion Lapierre

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Lapierre. A scholar is included among the top collaborators of Marion Lapierre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Lapierre. Marion Lapierre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jalaguier, Stéphan, Sandrine Bonnet, Catherine Teyssier, et al.. (2024). RIP140 regulates transcription factor HES1 oscillatory expression and mitogenic activity in colon cancer cells. Molecular Oncology. 18(6). 1510–1530. 1 indexed citations
2.
Mallavialle, Aude, Julien Faget, Lindsay B. Alcaraz, et al.. (2023). Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer. British Journal of Pharmacology. 183(6). 1288–1309. 9 indexed citations
3.
Lapierre, Marion, Sandrine Bonnet, Marie‐Jeanne Pillaire, et al.. (2022). RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells. Cancer Drug Resistance. 5(2). 401–415. 4 indexed citations
4.
Bonnet, Sandrine, Philippe Blache, Rong Yuan, et al.. (2021). RIP140 Represses Intestinal Paneth Cell Differentiation and Interplays with SOX9 Signaling in Colorectal Cancer. Cancers. 13(13). 3192–3192. 4 indexed citations
5.
Salehi, Hamideh, et al.. (2021). Adsorption of proteins on TiO2 particles influences their aggregation and cell penetration. Food Chemistry. 360. 130003–130003. 8 indexed citations
6.
Jalaguier, Stéphan, Catherine Teyssier, Sandrine Bonnet, et al.. (2017). Complex regulation of LCoR signaling in breast cancer cells. Oncogene. 36(33). 4790–4801. 23 indexed citations
7.
Lapierre, Marion, et al.. (2017). Expression and role of nuclear receptor coregulators in colorectal cancer. World Journal of Gastroenterology. 23(25). 4480–4480. 20 indexed citations
8.
Laprévotte, Emilie, Aurélie Docquier, Jérémy Bastid, et al.. (2017). Abstract 1602: Generation of anti-IL-17B antibodies neutralizing IL-17B-mediated alterations of the immune microenvironment, promotion of tumor cell initiating capacity and chemoresistance. Cancer Research. 77(13_Supplement). 1602–1602. 1 indexed citations
9.
Lapierre, Marion, Mathieu Dalvai, Céline Duraffourd, et al.. (2016). Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors. Oncotarget. 7(15). 19693–19708. 47 indexed citations
10.
Lapierre, Marion, Aurélie Docquier, Delphine Gitenay, et al.. (2015). The emerging role of the transcriptional coregulator RIP140 in solid tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1856(1). 144–150. 21 indexed citations
11.
Lapierre, Marion, Delphine Gitenay, Stéphan Jalaguier, et al.. (2015). Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia. Journal of Hematology & Oncology. 8(1). 20–20. 17 indexed citations
12.
Lapierre, Marion, Sandrine Bonnet, Caroline Mollévi, et al.. (2014). RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis. Journal of Clinical Investigation. 124(5). 1899–1913. 41 indexed citations
13.
Cavaillès, Vincent & Marion Lapierre. (2014). Regulation of intestinal homeostasis and tumorigenesis by the transcriptional coregulator RIP140. Molecular & Cellular Oncology. 1(2). e960761–e960761. 2 indexed citations
14.
Lapierre, Marion, Aurélie Docquier, Stéphan Jalaguier, et al.. (2013). Dialogue between estrogen receptor and E2F signaling pathways: The transcriptional coregulator RIP140 at the crossroads. Advances in Bioscience and Biotechnology. 4(10). 45–54. 1 indexed citations
15.
16.
Docquier, Aurélie, Patrick Augereau, Marion Lapierre, et al.. (2012). The RIP140 Gene Is a Transcriptional Target of E2F1. PLoS ONE. 7(5). e35839–e35839. 24 indexed citations
17.
Badia, Éric, Aurélie Docquier, Muriel Busson, et al.. (2012). Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 132(1-2). 176–185. 9 indexed citations
18.
Duclot, Florian, Marion Lapierre, R White, et al.. (2011). Cognitive impairments in adult mice with constitutive inactivation of RIP140 gene expression. Genes Brain & Behavior. 11(1). 69–78. 32 indexed citations
19.
Khatib, Abdel‐Majid, Yannick Bontemps, Marion Lapierre, Géraldine Siegfried, & Fabien Calvo. (2008). Inhibitory Feature of the Proprotein Convertases Prosegments. Medicinal Chemistry. 4(2). 116–120. 4 indexed citations
20.
Lapierre, Marion, Géraldine Siegfried, Nathalie Scamuffa, et al.. (2007). Opposing Function of the Proprotein Convertases Furin and PACE4 on Breast Cancer Cells' Malignant Phenotypes: Role of Tissue Inhibitors of Metalloproteinase-1. Cancer Research. 67(19). 9030–9034. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margarite D. Matossian Breakdown of academic impact, for papers by BaoHan T. Vo Breakdown of academic impact, for papers by Vijay Menon Breakdown of academic impact, for papers by Kristina Althoff Breakdown of academic impact, for papers by Jörg Hartkamp Breakdown of academic impact, for papers by Katarzyna Wójcik‐Krowiranda Breakdown of academic impact, for papers by William J. Muller Breakdown of academic impact, for papers by Kiran Nakka Breakdown of academic impact, for papers by M. Ángeles Villaronga Breakdown of academic impact, for papers by Suzana Gomes
Rankless by CCL
2026